“On Jan. 1, 2027, Dexcom is off-formulary on my Aetna health plan, and Abbott Freestyle Libre is on. I’m OK with it, except about a brand new CGM Prior Authorization ¶ mandate Caremark is implementing. Non-medical switches on medical devices and medicines are all about rebate kickbacks to the insurance company-owned PBM, not cost containment. Catch my blog post at Scott's Web Log: Dexcom Is Out. Libre Is In. I'm Happy, Except About the Prior Authorization (PA).”
A new prior authorization for a CGM, from the parent company bragging that it’s cutting them.
Come January, people on at least one plan from Aetna, a CVS Health Company will need a prior authorization for their CGM that they never needed before, from a company that says it’s cutting them. Scott Strumello, a longtime advocate in the diabetes community, shared this news on his blog…His plan is dropping Dexcom and making FreeStyle Libre the preferred CGM, with the same quantity limits and a brand-new prior authorization on top.
In June 2025, health insurers publicly pledged to fix prior authorization. CVS Health, which owns both Aetna and CVS Caremark, keeps saying it is reducing them. Then it adds one to a device people with diabetes depend on every hour of every day. And the formulary isn’t any more open: one brand is in, the other is out. WHY?
Now look at what that means for the patient.
Get your endo’s office to file the PA before January 1, or risk a gap in sensors.
Learn a new sensor and a new app.
If your insulin pump talks to your Dexcom, figure out what happens to your automated insulin delivery.
Call the pharmacy, call the plan, call again.
People with diabetes already carry more paperwork than ever, and for the young adults we serve at The Link, often on their first employer plan, it’s one more thing to learn the hard way.
If your plan is changing CGM coverage for 2027, check now whether a prior authorization is required and give your endo’s office an early heads-up. Then tell me in the comments what your plan sent you.
In case you are affected by this, And some of the time it depends on what plan you have from an employer etc.
An appeal from your doctor can work in many cases. Before Medicare when they removed Humalog from the formulary I was able to get it approved, but at a higher cost, tier 3.
With Medicare, this year my plan through a past employer chose CVS Silverscripts and it dropped Omnipod Dash, Humalog and Afrezza from the formulary, my doctor appealed it and it was approved. Again though it is at tier 3 in cost. It went pretty easy, next year who knows. They could decide to make the appeal process more laborious and difficult and not work. They are really pushing generic drugs and you choosing an alternative generic instead of a brand name drug. In my case the above items had no alternative and the letter I got turning my scripts down even stated that. That could be why it was approved on appeals so fast.
I get Dexcom through DME through Medicare, so this new change shouldn’t affect me. Dexcom charges way to much for their sensors and since Medicare has started bargaining with companies (can’t blame them) I could see them cutting a better deal with Abbot. Especially since Dexcom has proven many times over they are perfectly capable at putting sensors out at a cheaper price. For years they have charged UK customers a much cheaper price for the exact same sensor and now they have come out with an even cheaper version there and here. You can’t calibrate the new cheaper versions, but it is supposed to be pretty much the same thing. Calibration is important to me as mine are oftentime off by 30-40 points.
This is where a good and helpful endo can be critical for our scripts.
This only affects people on (US) Medicare who use Part C, and maybe not then. On original Medicare CGMs and blood test strips are paid for by Part B. In my case I had to go to a mail order supplier (the local pharmacies wouldn’t fill the prescription).
For Omnipod on Medicare the coverage depends on Part C vs Original too. Insulet’s list is here:
but that may be incomplete and it is for Omnipod 5 (I use Dash). O5 supports both Dexcom and Abbott so the swap shouldn’t be a problem but other commercial AID systems may not.
@jbowler I am on Medicare now, so CGM supplies are through Part B and won’t be affected by the change mentioned above and completely covered.
Re: Omnipods The classification for Omnipods before Medicare were the Omnipods were DME. But now under Medicare it’s Part D Formulary/Medicare, and through my husbands past employer switched to a Silverscripts plan through CVS instead of Optum. They are trying to trim costs and are really pushing people to go on generic drugs. Omnipods are uniquely classified under Part D and were dropped from the current formulary, however on appeal it has been approved and filled. I am not on Part C. I am Part A, Part B and Part D with a gap policy. The Part D and the gap is through my husbands past employer. I believe there is always an appeal process when you are turned down for what is deemed as a necessity, but it doesn’t always get approved.
To make it worse for Omnipod it isn’t enough to use Medicare.gov because even today the Omnipod does not appear on the formulary. If you do get the opportunity to swap a Part D, as I have, Insulet are are really good resource because they will go through the Part D policies that are available and get the coverage information. I did that last year.
If you have a good Part D and it is paid for by someone else stick with it; the appeal process should always work because changing to a tubed pump is obviously a major medical decision.
This year the Part D prices are going through the roof. All my available plans have a deductible of $700 (the maximum permitted) or a premium which is more than $1200 higher than the high-deductible options. The OOPMax has gone up from $2100 to $2400.
Price-wise Part C plans seem to be even worse. Ignoring the one MA-only plan that is available where I live most of them have a $0 premium with a $7150-$7900 OOPMax. The MA-PD plans with a non-zero premium sometimes have a lower OOPMax but in my experience the premium plays the plan for all or most of the difference (this was certainly true with ACA plans.)
EDIT: the above OOPMax ($7150-$7900) does not include the prescription drug max, which is apparently the same as Original Part D ($2400). The $0 premiums therefore have an OOPMax of $9,550-$10,300. I hadn’t realised that before.
Got my letter today. Would love to know what the deal between Abbott and Caremark was. I assume it more about increasing Abbott’s marketshare than any cost savings to my insurance plan.
I just checked the 20227 Aetna CVS CAREMARK Verizon formulary and Dexcom is available.
This doesn’t affect me one way or the other as my Dexcom and pump supplies are DME Medicare Part B even though I’m on Medicare Advantage plan as a retiree benefit.
Worth asking what “FREESTYLE LIBRE CONTINUOUS GLUCOSE MONITORING SYSTEM” they mean, since there are at least 5 different ones, I think. ATM Abbott are listing the “Libre 2” and “Libre 3” plus the “Libre Duo” as “coming soon”. The latter is the one with the blood ketone measurements. Both the numbered Libres come in “original” and “plus” flavours.
I’m trying to get the Libre 3+ now; I just talked to my endo about a swap from the G7 (10 day in my case) to the 3+, but I’m on Medicare of course so that should not be a problem, or will it?
My opinion on forced swaps caused by insurance is that the best approach is to do it now; ASAP and keep hold of the traditional diabetic squirrel stock of the old stuff. That way if the new stuff doesn’t work we have a stock of old stuff while the appeal is in progress. More than that the insurer can’t require “step therapy”, or whatever they call that variety of a PiP, because it’s already been done.
Assuming you do sign up with Abbott use the Libre app; it supports all the current sensors whereas there are credible reports of bugs in the other apps resulting in lost sensors (they get replaced but that’s always tedious).
If you choose the Duo watch out for app problems…
The app compatibility seems to be lazily enforced; some of the tech bro products we use simply refuse to run on any 'phone they don’t recognise (or is it, “Get paid to support, directly or indirectly?”) I was able to install the app, which I shall call Liberace since that seems inappropriate, on my 'phone with only a minor whine. I’ve yet to get any sensors so I’m going to have to wait to experience total systems meltdown. Nevertheless I live in hope.
There could be an argument for appeal that the LIbre is not equivalent to a Dexcom. The Dexcom can be calibrated, the Libre can’t. I have worn both and sometimes at the same time when I have been snorkeling. The LIbre isn’t bad per see, but it can be 40 points off. I look at the trend a lot when swimming and need to know what my BG levels are doing on long swims. My uncalibrated Dexcom can be 40 points off too before I calibrate it. I’ve even woken to a brand new not yet calibrated Dexcom the next morning reading 80 points over what my BG level was or way under.
If you want to appeal, you will probably have to try the Libre and then keep a record of it’s reading with a comparative reading on a BG meter. And if it is enough of a difference you might be able to appeal. What that difference that is enough I have no idea.
Should not be a problem getting it on Medicare. I tried it earlier this year, I think it was covered as DME and supplied by the same mail order (Edwards) that supplied the Dexcom. The problem I and others had with Libre 3+ is no way to calibrate. My preference today, (which might change tomorrow) is the Eversense 365. It can be a hassle to schedule an insertion of the sensor but once it is in your arm it is trouble free. No more re-orders every 30 or 90 days. There’s a comfort in taking a re-order off ones plate for a year.
Just called and checked mine, GIC Caremark. Yup, Dexcom off approved list. I’ll have to do DME mail order, and of course its a different company than we already use for CPAP. Grr…
Juggluco and, IRC, xDrip+ both offer calibration. xDrip+ also supposedly supports calibration of the G7 but it just sends the BG reading to the transmitter and the transmitter rapidly reverts to the old values. As a result I only calibrate the G7 when it is giving completely insane readings and, even then, it doesn’t normally help.
Juggluco seems to be required with the Libre3+ and there is some lack of clarity whether it will work with the US model. My order is now “pending review” from Edwards, which means they are waiting for the last Dexcom order to reach its refill date. I expect to have to do some experiment to establish the rules for the US sensors; anyone trying this in the US should read the Juggluco release notes carefully because it looks like the version on the Google Play Store will not work (installing the latest version is easy.)
The Juggluco calibration algorithm was apparently offered only grudgingly by the dev and I completely understand that. It seems like it might be broadly consistent with the EverSense continuous-calibration approach if done regularly (i.e. like the EverSense).
I will likely do DME unless it’s cost prohibitive. I just don’t have the time or desire to mess around with a new CGM. Been with Dexcom since SEVEN and while it not perfect it is what I know.
I have to admit the whole Part C thing leaves me completely confused. I assumed that when they did it as a pharmacy benefit they still billed Medicare on Part B; they just did the Medicare rules themselves and maybe paid themselves if the patient did not pass those rules, or maybe…
I don’t see why your cost as DME would be any different to your cost as a pharmacy benefit but I’ll certainly be interested to find out what happens!
I guess if you have TRICARE or an employer retirement benefit that might have been picking up the slack and will drop out, but for me on “Original” anything on Part B (including all CGMs and, for that matter, blood test strips) costs at absolute most an incremental $283 this year and an estimated $292 next year. That’s because I have a Medigap which picks up the slack (of course I pay the premia for that.)
If Juggluco doesn’t work for the Libre3+ I’ll just swap to the tech bros Tandem pump and, while I might die a whole lot sooner, I’ll save a lot of money for my heirs; Tandem+Libre3+ costs the same as Libre3+ or any other CGM but saves the $2400 I will otherwise pay next year for the Omnipod. (So O5 and twiist aren’t options; Tandem seems to have a monopoly ATM.)
Does this help us w/ these formulary problem? No. Not quickly. But this kinda stuff helps long term. The other helpful thing is that a lot of employers/companies are refusing to do biz w/ the Big Three PBMs (CVS is one of those). That helps faster.